Pulmonary Hypertension Imaging
No Results
No Results
processing….
Normal pulmonary circulation is a high-flow, low-resistance circuit capable of accommodating the entire right ventricular output at one fifth the pressure of the systemic circulation level. The thin-walled right ventricle functions primarily as a flow-generator pump and is particularly sensitive to increases in its afterload. Increased pulmonary artery pressure and pulmonary vascular resistance characterize pulmonary hypertension. Pulmonary hypertension may be divided into primary and secondary forms. Primary pulmonary hypertension (PPH) is a disease of unknown etiology, whereas secondary pulmonary arterial hypertension (SPAH) is due to either intrinsic parenchymal disease of the lung or disease extrinsic to the lung. [1, 2]
In an individual with suspected pulmonary hypertension, PPH is the diagnosis of exclusion. Hence, a designated algorithm should be used to exclude secondary causes of pulmonary hypertension. The following are proposed investigations [3] :
Autoantibody tests, HIV test, liver function tests
Electrocardiography
Chest radiography
Pulmonary function tests
Echocardiography
Ventilation-perfusion (V/Q) scanning
Computed tomographic pulmonary angiography (CTPA)
Pulmonary angiography
Cardiac catheterization
Magnetic resonance imaging (MRI)
As a baseline, the first 5 tests are reasonable for substantiating the presence of increased pressures on the right side of the pulmonary vascular system. On the basis of the results, a more focused approach to establish the etiology of the pulmonary hypertension may then involve tests 6-10. Most patients with secondary pulmonary hypertension do not require right-heart catheterization before beginning a trial with vasodilators. However, select patients, such as those with collagen vascular disease, should undergo invasive investigations. [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 2, 15]
The purposes of imaging studies in individuals with pulmonary hypertension are as follows:
Detecting pulmonary hypertension (echocardiography, cardiac catheterization)
Differentiating the cause (echocardiography, V/Q scanning, CTPA, cardiac catheterization, pulmonary angiography, MRI)
Determining the severity (echocardiography, cardiac catheterization)
Evaluating the status of the right ventricle (echocardiography, cardiac catheterization, MRI)
Various imaging modalities, including chest radiography, CT, MRI, pulmonary function tests, echocardiography, and angiography, have variable success in detecting the presence and severity of pulmonary hypertension.
Electrocardiograms are useful for demonstrating signs of right ventricular hypertrophy and strain. These signs include the following:
Right-axis deviation
R/S ratio greater than 1 in lead V1
Right atrial enlargement as indicated by an increased P-wave amplitude in lead II
Right bundle branch block
PPH is diagnosed if no underlying etiology is found.
(See the images below.)
Chest radiographs reveal a number of findings in pulmonary hypertension and may assist in the differential diagnosis of PH by showing signs suggesting lung disease or pulmonary venous congestion due to left heart disease. Chest radiography may help in distinguishing between arterial and venous PH by respectively demonstrating increased and decreased artery-to-vein ratios. [3]
(See the image below.)
Findings in patients with pulmonary artery hypertension (PAH) include central pulmonary arterial dilatation, which contrasts with ‘pruning’ (loss) of the peripheral blood vessels. [3]
A dilated right heart due to right ventricular enlargement is seen as a decrease in the retrosternal space on the lateral image. Right atrial enlargement may be present if significant tricuspid regurgitation is present. This finding may be recognized by the widened right heart border in the frontal projection and enlargement of the right atrial appendage in the lateral projection, which is seen as increased retrosternal opacity above the expected location of the right ventricle.
Peripheral vessel opacity-oligemic lung fields may be observed. This oligemia may be asymmetrical. This is also a useful finding suggestive of chronic pulmonary embolism (PE).
An increase in the transverse diameter of the right interlobar artery is indicative of pulmonary hypertension. The upper limit of the transverse diameter of the right interlobar artery from its lateral aspect to the intermediate bronchus is 15 mm in women and 16 mm in men.
The transverse diameter of the left interlobar artery is difficult to appreciate on the posteroanterior (PA) view. Using a lateral view, one can measure from the circular lucency of the left upper lobe bronchus to the posterior margin of the vessel; the upper limit is 18 mm.
Evidence of right atrial dilatation and right ventricular dilatation may be noted.
Kerley B lines may be present. These indicate the presence of pulmonary venous hypertension.
Atrial septal defect is characterized by cardiomegaly, enlargement of the right atrium and ventricle, and enlargement of the central pulmonary arteries. Also present is rapid tapering, with increased vascularity in the periphery of the lung.
Eisenmenger syndrome is characterized by peripheral oligemia, indicating the reversal of a left-to-right shunt due to increased vascular resistance. The peripheral vasculature is diminished, and the cardiac morphology is consistent with cor pulmonale.
CT scanning is a useful, noninvasive procedure for confirming the presence of pulmonary hypertension. CT pulmonary angiography (CTPA) is useful in delineating the anatomic detail of the pulmonary vasculature (see the image below). CTPA is the best method for demonstrating emboli. Contrast-enhanced images may show intraluminal abnormalities in the arteries and veins, which are useful for confirming etiologies such as thromboembolic disease. [4, 5, 16, 6, 7, 17, 13, 14, 18, 15]
Sometimes, if the emboli are large, they may be seen in the pulmonary arteries on routine contrast-enhanced CT scans.
CTPA, and often conventional pulmonary arteriography, is necessary for an adequate evaluation of chronic PE. The technique of CTPA includes a rapid infusion at 3-4 mL/sec for a total of 80-120 mL. Careful review of the images on a workstation is the optimal method of detecting subtle emboli. Evaluation of the lung windows to detect abnormalities of perfusion (mosaic perfusion) is necessary, as occlusions of major pulmonary arterial branches may not be present in a subset of patients with chronic pulmonary thromboembolism.
High-resolution CT (HRCT) scanning of the chest has a role in the evaluation of pulmonary hypertension in patients with suspected diffuse lung disease (eg, in patients with collagen vascular disease).
The upper limit of normal for the diameter of the pulmonary artery is 28.6 mm. A value greater than 28.6 mm suggests increased pressures in the pulmonary system.
(See the image below.)
Dual-energy computed tomography (DECT) of the chest provides a combined morphologic and functional analysis of the lung, usually obtained in a single acquisition without extra radiation or injection of extra intravenous iodine contrast. DECT enables the ability to quantitatively characterize the material properties of soft tissues, including the distal pulmonary vasculature. [8] Perfusion measured with DECT has an excellent correlation with the perfusion measured with pulmonary scintigraphy. [9]
MRI with contrast enhancement allows one to distinguish between the pulmonary vasculature and mediastinal adenopathy. [5, 7, 10, 11, 19]
MRI has capabilities similar to those of echocardiography in the diagnosis and treatment of patients with pulmonary hypertension. MRI is useful for measuring the mass, volume, and overall function of the right ventricle. [8] MRI is also useful for detecting shunt lesions contributing to pulmonary hypertension. Acute and chronic pulmonary thromboembolic disease can be confirmed by using this imaging modality.
The disadvantages with MRI include limitations in individuals with cardiac pacemakers and defibrillators, its limited availability and cost, and difficulty in assessing estimate PA pressures with MRI.
Two-dimensional (2D) Doppler echocardiography remains the most commonly used imaging modality for cardiac and hemodynamic evaluation in PH. However, while echocardiography can assist in determining whether left heart disease or congenital heart disease is the cause of PH, several other causes of PH (eg, lung disease, chronic thromboembolic disease) require additional imaging modalities. [8]
In evaluating pulmonary hypertension, echocardiography can be used to identify secondary causes, such as congenital, valvular, and myocardial disease. In addition, one may estimate pulmonary artery systolic pressure with this method. [20] Specifically, the World Health Organization (WHO) has defined pulmonary hypertension as a systolic pressure greater than 30 mm Hg; this corresponds to a tricuspid regurgitant velocity of 3.0 m/s on echocardiography.
The following findings for pulmonary hypertension are confirmed on echocardiography: (1) right atrial and ventricular enlargement, and (2) paradoxical movement of the interventricular septum and tricuspid regurgitation. (If right ventricular end-diastolic pressures are greater than 20 mm Hg, the risk of sudden death is relatively high.)
Doppler echocardiography is the most reliable noninvasive method for estimating pulmonary artery pressure. Tricuspid regurgitation is often present in pulmonary hypertension. It is detected in more than 90% of patients with severe pulmonary hypertension, with a correlation of more than 95% when the pressure is measured by means of catheterization. [12, 21]
Radioisotope perfusion lung scanning is performed with intravenous injection of particles of albumin labeled with technetium-99m. As these particles perfuse the lung, the lungs are imaged by using a gamma camera to obtain anterior, posterior, lateral, and oblique views. One would expect a normal distribution of these particles, which produce 2 blackened lung-shaped shadows.
In primary pulmonary hypertension (PPH), the V/Q scan is usually normal.
In secondary pulmonary hypertension due to chronic thromboembolic disease, emboli are responsible for blocking the branches of the pulmonary artery. The lung tissue peripheral to the block is not perfused; this block results in a defect on the scan. When findings in the perfusion scan are abnormal, a ventilation scan is obtained next by using inhalational radioactive xenon-133. A number of lung diseases, including pneumonia and COPD, can cause alterations in the ventilation component, whereas uncomplicated PE does not. Thus, a patient with a high likelihood of PE has an abnormal perfusion scan with a normal ventilation component. (See the image below.)
Right heart catheterization may be required. Pulmonary angiography is the most accurate modality for evaluating the anatomy and pathophysiology of pulmonary hypertension. This examination is the criterion standard for the diagnosis of pulmonary hypertension. (See the images below.)
Pulmonary angiography should be performed when the results of V/Q scanning cannot exclude chronic thromboembolic disease as an etiology for the elevated pulmonary pressures. The angiogram reveals large central pulmonary arteries with marked peripheral tapering.
The disadvantage of pulmonary angiography is that it is an invasive procedure, as one cannulates the right side of the heart and the pulmonary artery. Complications include (1) transient rhythm disturbances that respond to the removal of the catheter, (2) cardiac perforation leading to pericardial tamponade, and (3) nephrotoxicity. In patients with an elevated creatinine level (1.5 times normal), the use of high-osmolar contrast material poses a risk of nephrotoxicity. This problem is less commonly seen with the selective use of small amounts of low-osmolar nonionic contrast material. The frequency of complications with pulmonary angiography is limited to less than 5% of cases examined.
Oldroyd SH, Bhardwaj A. Pulmonary Hypertension. 2018 Jan. [Medline]. [Full Text].
Ascha M, Renapurkar RD, Tonelli AR. A review of imaging modalities in pulmonary hypertension. Ann Thorac Med. 2017 Apr-Jun. 12 (2):61-73. [Medline].
Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016 Jan 1. 37 (1):67-119. [Medline]. [Full Text].
Revel MP, Faivre JB, Remy-Jardin M, Delannoy-Deken V, Duhamel A, Remy J. Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology. 2009 Feb. 250(2):558-66. [Medline].
Koito H. [The findings of computed tomography (CT) and magnetic resonance imaging (MRI) in pulmonary arterial hypertension]. Nippon Rinsho. 2008 Nov. 66(11):2114-23. [Medline].
Wijesuriya S, Chandratreya L, Medford AR. Chronic Pulmonary Emboli and Radiologic Mimics on CT Pulmonary Angiography: A Diagnostic Challenge. Chest. 2013 May. 143(5):1460-71. [Medline].
Schiebler ML, Bhalla S, Runo J, Jarjour N, Roldan A, Chesler N, et al. Magnetic Resonance and Computed Tomography Imaging of the Structural and Functional Changes of Pulmonary Arterial Hypertension. J Thorac Imaging. 2013 May. 28(3):178-195. [Medline].
Freed BH, Collins JD, François CJ, Barker AJ, Cuttica MJ, Chesler NC, et al. MR and CT Imaging for the Evaluation of Pulmonary Hypertension. JACC Cardiovasc Imaging. 2016 Jun. 9 (6):715-32. [Medline]. [Full Text].
Hachulla AL, Lador F, Soccal PM, Montet X, Beghetti M. Dual-energy computed tomographic imaging of pulmonary hypertension. Swiss Med Wkly. 2016. 146:w14328. [Medline]. [Full Text].
Kovacs G, Reiter G, Reiter U, Rienmüller R, Peacock A, Olschewski H. The emerging role of magnetic resonance imaging in the diagnosis and management of pulmonary hypertension. Respiration. 2008. 76(4):458-70. [Medline].
Moledina S, Pandya B, Bartsota M, Mortensen KH, McMillan M, Quyam S, et al. Prognostic Significance of Cardiac Magnetic Resonance Imaging in Children with Pulmonary Hypertension. Circ Cardiovasc Imaging. 2013 Apr 9. [Medline].
Vargas PE, Lopez-Candales A. Essential echocardiographic evaluation in patients with suspected pulmonary hypertension: an overview for the practicing physician. Postgrad Med. 2015 Nov 30. 1-15. [Medline].
D’Alto M, Bossone E, Opotowsky AR, Ghio S, Rudski LG, Naeije R. Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension. Int J Cardiol. 2018 Apr 7. [Medline].
Aluja Jaramillo F, Gutierrez FR, Díaz Telli FG, Yevenes Aravena S, Javidan-Nejad C, Bhalla S. Approach to Pulmonary Hypertension: From CT to Clinical Diagnosis. Radiographics. 2018 Mar-Apr. 38 (2):357-373. [Medline].
Renapurkar RD, Shrikanthan S, Heresi GA, Lau CT, Gopalan D. Imaging in Chronic Thromboembolic Pulmonary Hypertension. J Thorac Imaging. 2017 Mar. 32 (2):71-88. [Medline].
Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology. 2008 Dec. 249(3):1042-9. [Medline].
Ando K, Kuraishi H, Nagaoka T, Tsutsumi T, Hoshika Y, Kimura T, et al. Potential Role of CT Metrics in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension. Lung. 2015 Dec. 193 (6):911-8. [Medline].
Grosse A, Grosse C, Lang IM. Distinguishing Chronic Thromboembolic Pulmonary Hypertension From Other Causes of Pulmonary Hypertension Using CT. AJR Am J Roentgenol. 2017 Dec. 209 (6):1228-1238. [Medline].
Swift AJ, Rajaram S, Capener D, Elliot C, Condliffe R, Wild JM, et al. Longitudinal and transverse right ventricular function in pulmonary hypertension: cardiovascular magnetic resonance imaging study from the ASPIRE registry. Pulm Circ. 2015 Sep. 5 (3):557-64. [Medline].
Kong D, Shu X, Dong L, Pan C, Cheng L, Yao H, et al. Right Ventricular Regional Systolic Function and Dyssynchrony in Patients with Pulmonary Hypertension Evaluated by Three-Dimensional Echocardiography. J Am Soc Echocardiogr. 2013 Apr 24. [Medline].
Giusca S, Popa E, Amzulescu MS, Ghiorghiu I, Coman IM, Popescu BA, et al. Is Right Ventricular Remodeling in Pulmonary Hypertension Dependent on Etiology? An Echocardiographic Study. Echocardiography. 2015 Nov 6. [Medline].
Galie N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009 Feb. 30(4):394-403. [Medline]. [Full Text].
Davinder Jassal, MD Academic Clinical Scientist, Cardiac Sciences Division, St Boniface Hospital Research; Assistant Professor of Cardiology and Radiology, Afffiliated Scientist of the Institute of Biodiagnostics at the National Research Council of Canada; Principal Investigator of the Cardiovascular Imaging Laboratory, Institute of Cardiovascular Sciences
Davinder Jassal, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, Canadian Medical Association
Disclosure: Nothing to disclose.
Sat Sharma, MD, FRCPC Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba Faculty of Medicine; Site Director, Respiratory Medicine, St Boniface General Hospital, Canada
Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, World Medical Association
Disclosure: Nothing to disclose.
Bruce Maycher, MD
Bruce Maycher, MD is a member of the following medical societies: American Roentgen Ray Society, Canadian Medical Association, Radiological Society of North America, Society of Thoracic Radiology
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Eugene C Lin, MD Attending Radiologist, Teaching Coordinator for Cardiac Imaging, Radiology Residency Program, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, Society of Nuclear Medicine and Molecular Imaging
Disclosure: Nothing to disclose.
Judith K Amorosa, MD, FACR Clinical Professor of Radiology and Vice Chair for Faculty Development and Medical Education, Rutgers Robert Wood Johnson Medical School
Judith K Amorosa, MD, FACR is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, Society of Thoracic Radiology
Disclosure: Nothing to disclose.
Pulmonary Hypertension Imaging
Research & References of Pulmonary Hypertension Imaging |A&C Accounting And Tax Services
Source
0 Comments